Neumora Therapeutics, Inc. (NMRA)
0.3672
-0.02
(-5.43%)
USD |
NASDAQ |
Oct 30, 16:00
0.3673
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Market Cap : 68.61M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 68.61M |
| October 29, 2026 | 72.55M |
| October 28, 2026 | 73.45M |
| October 27, 2026 | 68.78M |
| October 26, 2026 | 73.41M |
| October 23, 2026 | 70.89M |
| October 22, 2026 | 75.81M |
| October 21, 2026 | 77.73M |
| October 20, 2026 | 86.89M |
| October 19, 2026 | 87.82M |
| October 16, 2026 | 88.53M |
| October 15, 2026 | 79.79M |
| October 14, 2026 | 66.24M |
| October 13, 2026 | 69.17M |
| October 12, 2026 | 81.71M |
| October 09, 2026 | 88.88M |
| October 08, 2026 | 89.65M |
| October 07, 2026 | 87.50M |
| October 06, 2026 | 88.01M |
| October 05, 2026 | 98.15M |
| October 02, 2026 | 93.41M |
| October 01, 2026 | 102.77M |
| September 30, 2026 | 111.40M |
| September 29, 2026 | 126.61M |
| September 28, 2026 | 129.26M |
| Date | Value |
|---|---|
| September 25, 2026 | 126.61M |
| September 24, 2026 | 131.37M |
| September 23, 2026 | 136.64M |
| September 22, 2026 | 145.46M |
| September 21, 2026 | 129.26M |
| September 18, 2026 | 136.40M |
| September 17, 2026 | 140.14M |
| September 16, 2026 | 144.47M |
| September 15, 2026 | 155.33M |
| September 14, 2026 | 186.74M |
| September 11, 2026 | 194.32M |
| September 10, 2026 | 213.01M |
| September 09, 2026 | 224.22M |
| September 08, 2026 | 233.56M |
| September 04, 2026 | 244.77M |
| September 03, 2026 | 252.25M |
| September 02, 2026 | 257.85M |
| September 01, 2026 | 248.51M |
| August 31, 2026 | 248.51M |
| August 28, 2026 | 259.72M |
| August 27, 2026 | 276.54M |
| August 26, 2026 | 291.49M |
| August 25, 2026 | 280.28M |
| August 24, 2026 | 284.95M |
| August 21, 2026 | 304.57M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| EyePoint, Inc. | 29.61M |
| Context Therapeutics, Inc. | 17.37M |
| LENZ Therapeutics, Inc. | 95.82M |
| BioAge Labs, Inc. | 268.71M |
| ANI Pharmaceuticals, Inc. | 1.654B |
Market Cap Related Metrics
| Price to Book Value | 1.541 |
| Price | 0.3672 |
| Earnings Yield | -335.9% |